Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

27172 Press Releases
DateTitleCompany
15 Feb 18 Lupron: Global Drug Analysis and Forecasts to 2026 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Zoladex (GnRH): Global Drug Analysis and Forecasts 2017-2026 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Smith & Nephew: RCT demonstrates a 71% reduction in the onset of sacral pressure ulcers when adding ALLEVYN? LIFE to standard preventative protocol Smith & Nephew,
Published by
Business Wire
15 Feb 18 Ipatasertib: Global Drug Analysis and Forecasts 2017-2026 - A Combination with Zytiga? - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Global Drug Analysis: TetraVax-DV - A Potential Best-in-Class Live-Attenuated Vaccine - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 2018 Bevyxxa Drug Analysis Report: Approved in the US for the Prophylaxis of VTE in Adult Patients Hospitalized for an Acute Medical Illness - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 2018 Tecentriq (atezolizumab; Roche/Chugai) Drug Analysis: A Fully Humanized Monoclonal Antibody that Targets Programmed Death-Ligand 1 (PD-L1) - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Lynparza (Olaparib; AstraZeneca/Merck & Co) Drug Analysis 2018 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Darolutamide: Global Drug Analysis 2017 with Forecasts to 2026 - Strong Competition from Xtandi, Zytiga and Apalutamide - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Ra Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference Ra Pharmaceuticals,
Published by
Business Wire
15 Feb 18 2018 Xofigo (radium-223; Bayer) Drug Analysis: A Radioisotope that Kills Tumor Cells with Highly Localized Short-Range Alpha Irradiation - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Multikine Drug Analysis and Forecasts 2017-2026 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Global Schizophrenia Disease Coverage to 2024 - Pipeline, Marketed Drugs, Epidemiology, Treatment & Forecasts Analysis - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Global Colorectal Cancer Forecast and Market Analysis to 2036 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 2018 Masitinib Drug Analysis: An Oral Tyrosine Kinase Inhibitor Being Developed by AB Science - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Omeros Reports Significant Improvement in Overall Survival Data in OMS721-Treated Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy Omeros Corporation,
Published by
Business Wire
15 Feb 18 Global Chronic Heart Failure Market and Forecast Analysis to 2024 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Vetter Is a Winner of the Fraunhofer Clean Manufacturing Award CLEAN! 2018 Vetter Pharma International GmbH,
Published by
Business Wire
15 Feb 18 Shire plc : Director/PDMR Shareholding Published by
GlobeNewswire
15 Feb 18 Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use Published by
GlobeNewswire
15 Feb 18 Protalix BioTherapeutics Announces Final Dosing of Last Patient in Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis Published by
GlobeNewswire
15 Feb 18 Capital Senior Living Named One of the Top Senior Living Providers in J.D. Power Resident Satisfaction Survey Published by
GlobeNewswire
15 Feb 18 Merit Medical Closes Deal With BD for Purchase of Divestment Assets Published by
GlobeNewswire
15 Feb 18 RadNet, Inc. to Present at the RBC Capital Markets Healthcare Conference on February 21, 2018 Published by
GlobeNewswire
15 Feb 18 2018 Xtandi (enzalutamide; Pfizer/Astellas) Drug Analysis: An Androgen Receptor (AR) Signaling Inhibitor that Inhibits The AR at Three Distinct Points in the Signaling Pathway - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Global Neuroendocrine tumors (NET) Market Spotlight 2017-2027 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Three-way Collaboration with the U.S. Army, Harvard University and Frequency Therapeutics to Focus on Progenitor Cell Regeneration in Muscle Frequency Therapeutics,
Published by
Business Wire
15 Feb 18 Head and Neck Cancer Disease Analysis 2017 - Market is Projected to Reach $2.8bn in Value by 2026 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Avastin: Global Drug Analysis (2016-2017) with Forecasts to 2025 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
15 Feb 18 Imfinzi: Global Drug Analysis (2017) with Forecasts to 2026 - ResearchAndMarkets.com Research and Markets,
Published by
Business Wire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.